SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2gj4'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A7Y_A_DVAA2_0 (ACTINOMYCIN D)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 4	THR A 240 PRO A 229 THR A 228 PRO A 231	SO4 A 941 ( 4.4A) 2TH A 949 ( 4.8A) None None	1.34A	1a7yA-2gj4A: undetectable 1a7yC-2gj4A: undetectable	1a7yA-2gj4A: 1.25 1a7yC-2gj4A: 1.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.52A	1c8lA-2gj4A: 55.6	1c8lA-2gj4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.46A	1gfzA-2gj4A: 56.8	1gfzA-2gj4A: 99.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JNO_A_DVAA6_0 (GRAMICIDIN A)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ALA A 818 VAL A 827 TRP A 825	None	0.93A	1jnoA-2gj4A: undetectable	1jnoA-2gj4A: 1.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JNO_B_DVAB6_0 (GRAMICIDIN A)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ALA A 818 VAL A 827 TRP A 825	None	0.93A	1jnoB-2gj4A: undetectable	1jnoB-2gj4A: 1.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JO4_A_DVAA6_0 (GRAMICIDIN C)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ALA A 818 VAL A 827 TRP A 825	None	0.93A	1jo4A-2gj4A: undetectable	1jo4A-2gj4A: 1.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JO4_B_DVAB6_0 (GRAMICIDIN C)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ALA A 818 VAL A 827 TRP A 825	None	0.93A	1jo4B-2gj4A: undetectable	1jo4B-2gj4A: 1.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.44A	1l5qA-2gj4A: 55.0	1l5qA-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 4	TRP A 174 HIS A 614 LYS A 617 MET A 618	None	0.25A	1l5qA-2gj4A: 55.0	1l5qA-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.52A	1l5qB-2gj4A: 55.0	1l5qB-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5Q_B_CFFB1864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	TRP A 174 HIS A 614 MET A 618	None	0.24A	1l5qB-2gj4A: 55.0	1l5qB-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5R_A_RBFA859_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	11 / 11	ASN A 282 PHE A 285 LEU A 380 GLU A 382 HIS A 571 TYR A 573 ALA A 610 GLY A 612 TYR A 613 ARG A 770 PHE A 771	None	0.83A	1l5rA-2gj4A: 54.6	1l5rA-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L5R_A_RBFA859_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 11	HIS A 571 TYR A 573 ALA A 609 TYR A 613 ARG A 770 PHE A 771	None	1.49A	1l5rA-2gj4A: 54.6	1l5rA-2gj4A: 80.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7F_A_BCZA801_1 (NEURAMINIDASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ARG A 242 ARG A 81 ARG A 193	None None SO4 A 941 (-3.7A)	0.93A	1l7fA-2gj4A: undetectable	1l7fA-2gj4A: 18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7H_A_BCZA801_1 (NEURAMINIDASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ARG A 242 ARG A 81 ARG A 193	None None SO4 A 941 (-3.7A)	0.93A	1l7hA-2gj4A: undetectable	1l7hA-2gj4A: 18.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.42A	1l7xA-2gj4A: 54.5	1l7xA-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L7X_A_CFFA864_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	TRP A 174 HIS A 614 LYS A 617	None	0.22A	1l7xA-2gj4A: 54.5	1l7xA-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.46A	1l7xB-2gj4A: 54.4	1l7xB-2gj4A: 80.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NG8_A_DVAA6_0 (GRAMICIDIN A)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ALA A 818 VAL A 827 TRP A 825	None	0.93A	1ng8A-2gj4A: undetectable	1ng8A-2gj4A: 3.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NG8_B_DVAB6_0 (GRAMICIDIN A)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ALA A 818 VAL A 827 TRP A 825	None	0.92A	1ng8B-2gj4A: undetectable	1ng8B-2gj4A: 3.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NRU_A_DVAA6_0 (GRAMICIDIN A)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ALA A 818 VAL A 827 TRP A 825	None	0.94A	1nruA-2gj4A: undetectable	1nruA-2gj4A: 1.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NRU_B_DVAB6_0 (GRAMICIDIN A)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ALA A 818 VAL A 827 TRP A 825	None	0.94A	1nruB-2gj4A: undetectable	1nruB-2gj4A: 1.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q0Y_H_MOIH401_1 (FAB 9B1, HEAVY CHAIN FAB 9B1, LIGHT CHAIN)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 7	GLU A 385 GLU A 296 TRP A 387 LEU A 392	None	1.29A	1q0yH-2gj4A: undetectable 1q0yL-2gj4A: undetectable	1q0yH-2gj4A: 13.43 1q0yL-2gj4A: 12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QVU_A_PRLA196_0 (TRANSCRIPTIONAL REGULATOR QACR)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 6	LEU A 652 GLU A 646 THR A 624 TYR A 548	None	1.48A	1qvuA-2gj4A: undetectable	1qvuA-2gj4A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S8F_A_BEZA1501_0 (RAS-RELATED PROTEIN RAB-9A)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 5	ILE A 817 TRP A 825 LEU A 150 PRO A 829	None	1.46A	1s8fA-2gj4A: 7.1 1s8fB-2gj4A: 7.1	1s8fA-2gj4A: 13.26 1s8fB-2gj4A: 13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DM6_A_IMNA1401_1 (NADP-DEPENDENT LEUKOTRIENE B4 12-HYDROXYDEHYDROGEN ASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 10	TYR A 155 ILE A 82 ALA A 153 ILE A 307 ILE A 335	None	1.31A	2dm6A-2gj4A: 3.3 2dm6B-2gj4A: 3.4	2dm6A-2gj4A: 18.31 2dm6B-2gj4A: 18.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ECP_A_ACRA992_1 (MALTODEXTRIN PHOSPHORYLASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 10	ASN A 133 LEU A 136 ASP A 339 HIS A 341 ALA A 610	None	1.00A	2ecpA-2gj4A: 45.9	2ecpA-2gj4A: 43.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ECP_B_ACRB992_1 (MALTODEXTRIN PHOSPHORYLASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 10	ASN A 133 LEU A 136 ASP A 339 HIS A 341 ALA A 610	None	0.98A	2ecpB-2gj4A: 45.9	2ecpB-2gj4A: 43.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EJ3_C_GBNC1414_1 (BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 8	ARG A 309 GLU A 348 THR A 303 ALA A 302 ALA A 301	None	1.40A	2ej3C-2gj4A: undetectable	2ej3C-2gj4A: 17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HMA_A_SAMA375_0 (PROBABLE TRNA (5-METHYLAMINOMETHYL -2-THIOURIDYLATE)-ME THYLTRANSFERASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 11	GLY A 135 ASP A 693 THR A 676 GLY A 677 GLN A 665	PLR A 940 ( 3.8A) None PLR A 940 (-4.5A) PLR A 940 (-3.8A) PLR A 940 ( 4.4A)	1.47A	2hmaA-2gj4A: undetectable	2hmaA-2gj4A: 18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2M9Q_B_BEZB251_0 (SERINE PROTEASE INHIBITOR SERINE PROTEASE SUBUNIT NS2B, SERINE PROTEASE NS3)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 9	ILE A 308 ILE A 307 PHE A 326 THR A 371 LEU A 353	None	1.19A	2m9qA-2gj4A: undetectable	2m9qA-2gj4A: 14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2O4N_A_TPVA300_2 (PROTEASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 8	LEU A 499 GLY A 508 ILE A 507 LEU A 492	None	0.68A	2o4nB-2gj4A: undetectable	2o4nB-2gj4A: 8.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q6F_C_010C6_0 (INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE N-[(5-METHYLISOXAZOL -3-YL)CARBONYL]ALANY L-L-VALYL-N~1~-((1R, 2Z)-4-(BENZYLOXY)-4- OXO-1-{[(3R)-2-OXOPY RROLIDIN-3-YL]METHYL }BUT-2-ENYL)-L-LEUCI NAMIDE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	ASN A 133 LEU A 136 HIS A 341	None	0.87A	2q6fB-2gj4A: undetectable	2q6fB-2gj4A: 17.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W9H_A_TOPA1160_1 (DIHYDROFOLATE REDUCTASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 10	LEU A 474 ALA A 447 LEU A 430 LEU A 411 VAL A 414	None None None SO4 A 948 (-3.9A) None	1.03A	2w9hA-2gj4A: undetectable	2w9hA-2gj4A: 11.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WM3_A_NFLA1301_1 (NMRA-LIKE FAMILY DOMAIN CONTAINING PROTEIN 1)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 6	LEU A 117 PHE A 31 LEU A 55 ASP A 50	None	0.84A	2wm3A-2gj4A: 3.3	2wm3A-2gj4A: 17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZS9_A_PAUA603_0 (PANTOTHENATE KINASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 6	VAL A 455 ASP A 339 TYR A 84 ASN A 484	None	1.45A	2zs9A-2gj4A: undetectable	2zs9A-2gj4A: 18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ARU_A_PNXA607_1 (CHITINASE A)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 8	GLY A 675 THR A 676 GLU A 672 GLY A 694 ALA A 695	PLR A 940 (-3.3A) PLR A 940 (-4.5A) PLR A 940 ( 4.5A) None None	1.09A	3aruA-2gj4A: 2.2	3aruA-2gj4A: 21.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BCR_A_AZZA940_1 (GLYCOGEN PHOSPHORYLASE, MUSCLE FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 5	ASN A 282 PHE A 285 ALA A 610 GLY A 612 TYR A 613	None	0.36A	3bcrA-2gj4A: 57.4	3bcrA-2gj4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.47A	3dd1A-2gj4A: 54.0	3dd1A-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.45A	3dd1B-2gj4A: 54.0	3dd1B-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.49A	3ddsA-2gj4A: 54.2	3ddsA-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.50A	3ddsB-2gj4A: 54.4	3ddsB-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.47A	3ddwA-2gj4A: 54.1	3ddwA-2gj4A: 80.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 6	ASN A 282 PHE A 285 HIS A 571 ALA A 610 GLY A 612 TYR A 613	None	0.48A	3ddwB-2gj4A: 54.4	3ddwB-2gj4A: 80.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FRB_X_TOPX300_1 (DIHYDROFOLATE REDUCTASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 11	LEU A 474 ALA A 447 LEU A 430 LEU A 411 VAL A 414	None None None SO4 A 948 (-3.9A) None	1.07A	3frbX-2gj4A: undetectable	3frbX-2gj4A: 12.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H9U_B_ADNB438_1 (ADENOSYLHOMOCYSTEINA SE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 10	THR A 671 THR A 668 ASN A 284 LEU A 380 HIS A 571	None	1.16A	3h9uB-2gj4A: 5.5	3h9uB-2gj4A: 19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LP9_D_SPMD230_1 (LS-24)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	GLU A 672 GLU A 382 ASN A 284	PLR A 940 ( 4.5A) None None	0.88A	3lp9B-2gj4A: undetectable 3lp9D-2gj4A: undetectable	3lp9B-2gj4A: 14.09 3lp9D-2gj4A: 14.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MJR_A_AC2A301_1 (DEOXYCYTIDINE KINASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 9	ILE A 507 GLU A 505 ASP A 533 PHE A 530 LEU A 521	None	1.43A	3mjrA-2gj4A: 0.0	3mjrA-2gj4A: 16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3THR_A_C2FA1100_0 (GLYCINE N-METHYLTRANSFERASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 6	SER A 812 LEU A 683 THR A 487 ARG A 489	None	1.40A	3thrB-2gj4A: undetectable	3thrB-2gj4A: 15.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VW7_A_VPXA2001_1 (PROTEINASE-ACTIVATED RECEPTOR 1, LYSOZYME)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	LEU A 384 LEU A 463 ALA A 451 ALA A 373 TYR A 374	None	1.10A	3vw7A-2gj4A: undetectable	3vw7A-2gj4A: 19.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BQF_A_QPSA951_1 (ALPHA-GLUCAN PHOSPHORYLASE 2, CYTOSOLIC)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 6	TRP A 361 ARG A 398 GLU A 405 ARG A 409	None	0.59A	4bqfA-2gj4A: 46.9	4bqfA-2gj4A: 45.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BQF_B_QPSB951_1 (ALPHA-GLUCAN PHOSPHORYLASE 2, CYTOSOLIC)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 8	TRP A 361 ARG A 398 GLU A 405 ARG A 409	None	0.55A	4bqfB-2gj4A: 46.8	4bqfB-2gj4A: 45.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4D33_A_MTLA870_0 (NITRIC OXIDE SYNTHASE, ENDOTHELIAL)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 8	ASN A 440 GLU A 385 ASN A 376 ASP A 339	None	1.10A	4d33A-2gj4A: undetectable	4d33A-2gj4A: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4D33_B_MTLB870_0 (NITRIC OXIDE SYNTHASE, ENDOTHELIAL)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 7	ASN A 440 GLU A 385 ASN A 376 ASP A 339	None	1.10A	4d33B-2gj4A: undetectable	4d33B-2gj4A: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4D39_A_MTLA870_0 (NITRIC OXIDE SYNTHASE, ENDOTHELIAL)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 8	ASN A 440 GLU A 385 ASN A 376 ASP A 339	None	1.04A	4d39A-2gj4A: undetectable	4d39A-2gj4A: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4D39_B_MTLB870_0 (NITRIC OXIDE SYNTHASE, ENDOTHELIAL)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 7	ASN A 440 GLU A 385 ASN A 376 ASP A 339	None	1.08A	4d39B-2gj4A: undetectable	4d39B-2gj4A: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EYZ_A_CCSA109_0 (CELLULOSOME-RELATED PROTEIN MODULE FROM RUMINOCOCCUS FLAVEFACIENS THAT RESEMBLES PAPAIN-LIKE CYSTEINE PEPTIDASES)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 8	ASN A 481 PHE A 479 VAL A 452 HIS A 459 ALA A 673	None	1.35A	4eyzA-2gj4A: undetectable	4eyzA-2gj4A: 14.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EYZ_B_CCSB109_0 (CELLULOSOME-RELATED PROTEIN MODULE FROM RUMINOCOCCUS FLAVEFACIENS THAT RESEMBLES PAPAIN-LIKE CYSTEINE PEPTIDASES)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 8	ASN A 481 PHE A 479 VAL A 452 HIS A 459 ALA A 673	None	1.33A	4eyzB-2gj4A: undetectable	4eyzB-2gj4A: 14.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KT0_A_PQNA2001_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1 PHOTOSYSTEM I REACTION CENTER SUBUNIT IX)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 11	GLY A 135 ARG A 138 ALA A 141 GLY A 132 LEU A 198	PLR A 940 ( 3.8A) None None None None	1.06A	4kt0A-2gj4A: undetectable 4kt0J-2gj4A: undetectable	4kt0A-2gj4A: 22.56 4kt0J-2gj4A: 4.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5C0O_H_SAMH301_0 (TRNA (ADENINE(58)-N(1))-M ETHYLTRANSFERASE TRMI)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	ALA A 140 GLY A 132 GLY A 137 GLY A 135 LEU A 131	None None None PLR A 940 ( 3.8A) None	0.80A	5c0oH-2gj4A: undetectable	5c0oH-2gj4A: 15.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HYR_A_ESTA601_1 (ESTROGEN RECEPTOR)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 10	LEU A 222 ALA A 246 GLU A 273 ARG A 269 HIS A 201	None None None None SO4 A 942 ( 3.9A)	1.49A	5hyrA-2gj4A: undetectable	5hyrA-2gj4A: 15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KC4_E_RBFE201_2 (RIBOFLAVIN TRANSPORTER RIBU)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	LYS A 608 ASP A 283 ILE A 623	None	0.81A	5kc4E-2gj4A: undetectable	5kc4E-2gj4A: 12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N5D_A_SAMA306_1 (METHYLTRANSFERASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 7	LEU A 652 ILE A 125 GLU A 124 ASP A 128	None	0.96A	5n5dA-2gj4A: 3.1	5n5dA-2gj4A: 13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUD_D_ERMD1201_2 (5-HYDROXYTRYPTAMINE RECEPTOR 2B,SOLUBLE CYTOCHROME B562 CHIMERA)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 6	LEU A 198 VAL A 200 LEU A 349 GLU A 357	None	0.85A	5tudD-2gj4A: undetectable	5tudD-2gj4A: 19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UIG_A_EDTA501_0 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 6	ASN A 696 THR A 691 ILE A 458 GLU A 698	None	1.35A	5uigA-2gj4A: undetectable	5uigA-2gj4A: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VNC_C_GCSC801_1 (GLYCOGEN [STARCH] SYNTHASE ISOFORM 2)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	7 / 10	GLY A 135 HIS A 377 VAL A 455 ASN A 484 LYS A 574 GLU A 672 GLY A 675	PLR A 940 ( 3.8A) None None None PLR A 940 (-2.8A) PLR A 940 ( 4.5A) PLR A 940 (-3.3A)	0.70A	5vncC-2gj4A: 18.0	5vncC-2gj4A: 6.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6D8F_A_ACTA803_0 (UNCHARACTERIZED PROTEIN)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	GLU A 778 LEU A 738 ARG A 739	None	0.78A	6d8fA-2gj4A: 2.1	6d8fA-2gj4A: 22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EXI_A_ADNA502_0 (ADENOSYLHOMOCYSTEINA SE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	THR A 671 THR A 668 ASN A 284 LEU A 380 HIS A 571	None	1.17A	6exiA-2gj4A: 4.9	6exiA-2gj4A: 7.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EXI_B_ADNB502_0 (ADENOSYLHOMOCYSTEINA SE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	THR A 671 THR A 668 ASN A 284 LEU A 380 HIS A 571	None	1.16A	6exiB-2gj4A: 2.3	6exiB-2gj4A: 7.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EXI_C_ADNC502_0 (ADENOSYLHOMOCYSTEINA SE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	THR A 671 THR A 668 ASN A 284 LEU A 380 HIS A 571	None	1.15A	6exiC-2gj4A: 4.9	6exiC-2gj4A: 7.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EXI_D_ADND502_0 (ADENOSYLHOMOCYSTEINA SE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	THR A 671 THR A 668 ASN A 284 LEU A 380 HIS A 571	None	1.16A	6exiD-2gj4A: 3.7	6exiD-2gj4A: 7.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNE_A_ACRA602_1 (-)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 12	GLY A 134 GLY A 135 ASP A 339 VAL A 455 ASN A 484 GLY A 675	PLR A 940 (-3.6A) PLR A 940 ( 3.8A) None None None PLR A 940 (-3.3A)	0.69A	6gneA-2gj4A: 22.8	6gneA-2gj4A: 20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNE_B_ACRB602_1 (-)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	7 / 12	GLU A 88 GLY A 134 GLY A 135 ASP A 339 VAL A 455 ASN A 484 GLY A 675	None PLR A 940 (-3.6A) PLR A 940 ( 3.8A) None None None PLR A 940 (-3.3A)	0.78A	6gneB-2gj4A: 22.8	6gneB-2gj4A: 20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNF_A_QPSA602_1 (-)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	ASP A 339 HIS A 341 ASN A 484 GLU A 672 GLY A 675	None None None PLR A 940 ( 4.5A) PLR A 940 (-3.3A)	0.77A	6gnfA-2gj4A: 21.6	6gnfA-2gj4A: 21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNF_C_QPSC602_2 (-)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	ASP A 339 HIS A 341 ASN A 484 GLU A 672 GLY A 675	None None None PLR A 940 ( 4.5A) PLR A 940 (-3.3A)	0.76A	6gnfC-2gj4A: 21.9	6gnfC-2gj4A: 21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNG_A_QPSA601_1 (-)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	GLY A 134 LEU A 136 ASP A 339 HIS A 341 ASN A 484	PLR A 940 (-3.6A) None None None None	0.88A	6gngA-2gj4A: 21.8	6gngA-2gj4A: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNG_A_QPSA601_2 (-)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 12	GLU A 88 GLY A 135 HIS A 377 VAL A 455 GLU A 672 GLY A 675	None PLR A 940 ( 3.8A) None None PLR A 940 ( 4.5A) PLR A 940 (-3.3A)	0.72A	6gngA-2gj4A: 21.8	6gngA-2gj4A: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNG_B_QPSB601_2 (-)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	GLU A 88 GLY A 134 GLY A 135 GLY A 612 ASN A 284	None PLR A 940 (-3.6A) PLR A 940 ( 3.8A) None None	1.03A	6gngB-2gj4A: 21.8	6gngB-2gj4A: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNG_B_QPSB601_2 (-)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	6 / 12	GLU A 88 GLY A 134 GLY A 135 LEU A 136 HIS A 341 ASN A 284	None PLR A 940 (-3.6A) PLR A 940 ( 3.8A) None None None	1.12A	6gngB-2gj4A: 21.8	6gngB-2gj4A: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNG_B_QPSB601_2 (-)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 12	GLU A 88 GLY A 134 LEU A 136 HIS A 341 ASN A 284	None PLR A 940 (-3.6A) None None None	1.07A	6gngB-2gj4A: 21.8	6gngB-2gj4A: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HQB_A_PQNA2001_0 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1 PHOTOSYSTEM I REACTION CENTER SUBUNIT IX)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	5 / 10	GLY A 135 ARG A 138 ALA A 141 GLY A 132 LEU A 198	PLR A 940 ( 3.8A) None None None None	1.05A	6hqbA-2gj4A: undetectable 6hqbJ-2gj4A: undetectable	6hqbA-2gj4A: 6.92 6hqbJ-2gj4A: 4.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HZP_A_FVTA501_0 (PEPTIDE ABC TRANSPORTER PERMEASE)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 8	VAL A 629 GLN A 740 ASN A 588 ILE A 584	None	1.01A	6hzpA-2gj4A: undetectable	6hzpA-2gj4A: 21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6JI6_A_ACTA305_0 (GLUTATHIONE S-TRANSFERASE CLASS-MU 26 KDA ISOZYME)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 5	GLY A 137 LEU A 136 SER A 86 TYR A 84	None	0.95A	6ji6A-2gj4A: undetectable	6ji6A-2gj4A: 14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MA7_A_TPFA602_0 (CYTOCHROME P450 3A4)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 7	ARG A 398 ALA A 364 THR A 368 ILE A 346	None	0.97A	6ma7A-2gj4A: undetectable	6ma7A-2gj4A: 7.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN4_C_AM2C301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	4 / 8	ASP A 339 HIS A 443 HIS A 341 GLU A 382	None	1.15A	6mn4C-2gj4A: undetectable	6mn4C-2gj4A: 16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NJ9_K_SAMK500_1 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC)	2gj4	GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (Oryctolagus cuniculus)	3 / 3	THR A 378 GLU A 88 ASN A 284	None	0.56A	6nj9K-2gj4A: 4.0	6nj9K-2gj4A: 20.07

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1A7Y_A_DVAA2_0","ACTINOMYCIN D","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"THR A 240;PRO A 229;THR A 228;PRO A 231","SO4 A 941 ( 4.4A);2TH A 949 ( 4.8A);None;None","1.34A","1a7yA-2gj4A:undetectable;1a7yC-2gj4A:undetectable","1a7yA-2gj4A:1.25;1a7yC-2gj4A:1.25"],["1C8L_A_CFFA940_1","PROTEIN (GLYCOGEN PHOSPHORYLASE)","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.52A","1c8lA-2gj4A:55.6","1c8lA-2gj4A:100.00"],["1GFZ_A_CFFA940_1","GLYCOGEN PHOSPHORYLASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.46A","1gfzA-2gj4A:56.8","1gfzA-2gj4A:99.88"],["1JNO_A_DVAA6_0","GRAMICIDIN A","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ALA A 818;VAL A 827;TRP A 825","None","0.93A","1jnoA-2gj4A:undetectable","1jnoA-2gj4A:1.83"],["1JNO_B_DVAB6_0","GRAMICIDIN A","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ALA A 818;VAL A 827;TRP A 825","None","0.93A","1jnoB-2gj4A:undetectable","1jnoB-2gj4A:1.83"],["1JO4_A_DVAA6_0","GRAMICIDIN C","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ALA A 818;VAL A 827;TRP A 825","None","0.93A","1jo4A-2gj4A:undetectable","1jo4A-2gj4A:1.83"],["1JO4_B_DVAB6_0","GRAMICIDIN C","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ALA A 818;VAL A 827;TRP A 825","None","0.93A","1jo4B-2gj4A:undetectable","1jo4B-2gj4A:1.83"],["1L5Q_A_CFFA863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.44A","1l5qA-2gj4A:55.0","1l5qA-2gj4A:80.87"],["1L5Q_A_CFFA864_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"TRP A 174;HIS A 614;LYS A 617;MET A 618","None","0.25A","1l5qA-2gj4A:55.0","1l5qA-2gj4A:80.87"],["1L5Q_B_CFFB1863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.52A","1l5qB-2gj4A:55.0","1l5qB-2gj4A:80.87"],["1L5Q_B_CFFB1864_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"TRP A 174;HIS A 614;MET A 618","None","0.24A","1l5qB-2gj4A:55.0","1l5qB-2gj4A:80.87"],["1L5R_A_RBFA859_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",11,"ASN A 282;PHE A 285;LEU A 380;GLU A 382;HIS A 571;TYR A 573;ALA A 610;GLY A 612;TYR A 613;ARG A 770;PHE A 771","None","0.83A","1l5rA-2gj4A:54.6","1l5rA-2gj4A:80.87"],["1L5R_A_RBFA859_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"HIS A 571;TYR A 573;ALA A 609;TYR A 613;ARG A 770;PHE A 771","None","1.49A","1l5rA-2gj4A:54.6","1l5rA-2gj4A:80.87"],["1L7F_A_BCZA801_1","NEURAMINIDASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ARG A 242;ARG A  81;ARG A 193","None;None;SO4 A 941 (-3.7A)","0.93A","1l7fA-2gj4A:undetectable","1l7fA-2gj4A:18.59"],["1L7H_A_BCZA801_1","NEURAMINIDASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ARG A 242;ARG A  81;ARG A 193","None;None;SO4 A 941 (-3.7A)","0.93A","1l7hA-2gj4A:undetectable","1l7hA-2gj4A:18.59"],["1L7X_A_CFFA863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.42A","1l7xA-2gj4A:54.5","1l7xA-2gj4A:80.87"],["1L7X_A_CFFA864_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"TRP A 174;HIS A 614;LYS A 617","None","0.22A","1l7xA-2gj4A:54.5","1l7xA-2gj4A:80.87"],["1L7X_B_CFFB1863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.46A","1l7xB-2gj4A:54.4","1l7xB-2gj4A:80.87"],["1NG8_A_DVAA6_0","GRAMICIDIN A","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ALA A 818;VAL A 827;TRP A 825","None","0.93A","1ng8A-2gj4A:undetectable","1ng8A-2gj4A:3.21"],["1NG8_B_DVAB6_0","GRAMICIDIN A","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ALA A 818;VAL A 827;TRP A 825","None","0.92A","1ng8B-2gj4A:undetectable","1ng8B-2gj4A:3.21"],["1NRU_A_DVAA6_0","GRAMICIDIN A","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ALA A 818;VAL A 827;TRP A 825","None","0.94A","1nruA-2gj4A:undetectable","1nruA-2gj4A:1.83"],["1NRU_B_DVAB6_0","GRAMICIDIN A","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ALA A 818;VAL A 827;TRP A 825","None","0.94A","1nruB-2gj4A:undetectable","1nruB-2gj4A:1.83"],["1Q0Y_H_MOIH401_1","FAB 9B1, HEAVY CHAIN;FAB 9B1, LIGHT CHAIN","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"GLU A 385;GLU A 296;TRP A 387;LEU A 392","None","1.29A","1q0yH-2gj4A:undetectable;1q0yL-2gj4A:undetectable","1q0yH-2gj4A:13.43;1q0yL-2gj4A:12.74"],["1QVU_A_PRLA196_0","TRANSCRIPTIONAL REGULATOR QACR","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"LEU A 652;GLU A 646;THR A 624;TYR A 548","None","1.48A","1qvuA-2gj4A:undetectable","1qvuA-2gj4A:12.89"],["1S8F_A_BEZA1501_0","RAS-RELATED PROTEIN RAB-9A","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"ILE A 817;TRP A 825;LEU A 150;PRO A 829","None","1.46A","1s8fA-2gj4A:7.1;1s8fB-2gj4A:7.1","1s8fA-2gj4A:13.26;1s8fB-2gj4A:13.26"],["2DM6_A_IMNA1401_1","NADP-DEPENDENT LEUKOTRIENE B4 12-HYDROXYDEHYDROGENASE;NADP-DEPENDENT LEUKOTRIENE B4 12-HYDROXYDEHYDROGENASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"TYR A 155;ILE A  82;ALA A 153;ILE A 307;ILE A 335","None","1.31A","2dm6A-2gj4A:3.3;2dm6B-2gj4A:3.4","2dm6A-2gj4A:18.31;2dm6B-2gj4A:18.31"],["2ECP_A_ACRA992_1","MALTODEXTRIN PHOSPHORYLASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ASN A 133;LEU A 136;ASP A 339;HIS A 341;ALA A 610","None","1.00A","2ecpA-2gj4A:45.9","2ecpA-2gj4A:43.71"],["2ECP_B_ACRB992_1","MALTODEXTRIN PHOSPHORYLASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ASN A 133;LEU A 136;ASP A 339;HIS A 341;ALA A 610","None","0.98A","2ecpB-2gj4A:45.9","2ecpB-2gj4A:43.71"],["2EJ3_C_GBNC1414_1","BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ARG A 309;GLU A 348;THR A 303;ALA A 302;ALA A 301","None","1.40A","2ej3C-2gj4A:undetectable","2ej3C-2gj4A:17.60"],["2HMA_A_SAMA375_0","PROBABLE TRNA (5-METHYLAMINOMETHYL-2-THIOURIDYLATE)-METHYLTRANSFERASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"GLY A 135;ASP A 693;THR A 676;GLY A 677;GLN A 665","PLR A 940 ( 3.8A);None;PLR A 940 (-4.5A);PLR A 940 (-3.8A);PLR A 940 ( 4.4A)","1.47A","2hmaA-2gj4A:undetectable","2hmaA-2gj4A:18.35"],["2M9Q_B_BEZB251_0","SERINE PROTEASE INHIBITOR;SERINE PROTEASE SUBUNIT NS2B, SERINE PROTEASE NS3","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ILE A 308;ILE A 307;PHE A 326;THR A 371;LEU A 353","None","1.19A","2m9qA-2gj4A:undetectable","2m9qA-2gj4A:14.44"],["2O4N_A_TPVA300_2","PROTEASE;PROTEASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"LEU A 499;GLY A 508;ILE A 507;LEU A 492","None","0.68A","2o4nB-2gj4A:undetectable","2o4nB-2gj4A:8.68"],["2Q6F_C_010C6_0","INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE;N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"ASN A 133;LEU A 136;HIS A 341","None","0.87A","2q6fB-2gj4A:undetectable","2q6fB-2gj4A:17.23"],["2W9H_A_TOPA1160_1","DIHYDROFOLATE REDUCTASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"LEU A 474;ALA A 447;LEU A 430;LEU A 411;VAL A 414","None;None;None;SO4 A 948 (-3.9A);None","1.03A","2w9hA-2gj4A:undetectable","2w9hA-2gj4A:11.96"],["2WM3_A_NFLA1301_1","NMRA-LIKE FAMILY DOMAIN CONTAINING PROTEIN 1","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"LEU A 117;PHE A  31;LEU A  55;ASP A  50","None","0.84A","2wm3A-2gj4A:3.3","2wm3A-2gj4A:17.07"],["2ZS9_A_PAUA603_0","PANTOTHENATE KINASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"VAL A 455;ASP A 339;TYR A  84;ASN A 484","None","1.45A","2zs9A-2gj4A:undetectable","2zs9A-2gj4A:18.12"],["3ARU_A_PNXA607_1","CHITINASE A","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"GLY A 675;THR A 676;GLU A 672;GLY A 694;ALA A 695","PLR A 940 (-3.3A);PLR A 940 (-4.5A);PLR A 940 ( 4.5A);None;None","1.09A","3aruA-2gj4A:2.2","3aruA-2gj4A:21.15"],["3BCR_A_AZZA940_1","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ASN A 282;PHE A 285;ALA A 610;GLY A 612;TYR A 613","None","0.36A","3bcrA-2gj4A:57.4","3bcrA-2gj4A:100.00"],["3DD1_A_CFFA903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.47A","3dd1A-2gj4A:54.0","3dd1A-2gj4A:80.87"],["3DD1_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.45A","3dd1B-2gj4A:54.0","3dd1B-2gj4A:80.87"],["3DDS_A_CFFA904_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.49A","3ddsA-2gj4A:54.2","3ddsA-2gj4A:80.87"],["3DDS_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.50A","3ddsB-2gj4A:54.4","3ddsB-2gj4A:80.87"],["3DDW_A_CFFA903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.47A","3ddwA-2gj4A:54.1","3ddwA-2gj4A:80.87"],["3DDW_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"ASN A 282;PHE A 285;HIS A 571;ALA A 610;GLY A 612;TYR A 613","None","0.48A","3ddwB-2gj4A:54.4","3ddwB-2gj4A:80.87"],["3FRB_X_TOPX300_1","DIHYDROFOLATE REDUCTASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"LEU A 474;ALA A 447;LEU A 430;LEU A 411;VAL A 414","None;None;None;SO4 A 948 (-3.9A);None","1.07A","3frbX-2gj4A:undetectable","3frbX-2gj4A:12.09"],["3H9U_B_ADNB438_1","ADENOSYLHOMOCYSTEINASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"THR A 671;THR A 668;ASN A 284;LEU A 380;HIS A 571","None","1.16A","3h9uB-2gj4A:5.5","3h9uB-2gj4A:19.95"],["3LP9_D_SPMD230_1","LS-24;LS-24","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"GLU A 672;GLU A 382;ASN A 284","PLR A 940 ( 4.5A);None;None","0.88A","3lp9B-2gj4A:undetectable;3lp9D-2gj4A:undetectable","3lp9B-2gj4A:14.09;3lp9D-2gj4A:14.09"],["3MJR_A_AC2A301_1","DEOXYCYTIDINE KINASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ILE A 507;GLU A 505;ASP A 533;PHE A 530;LEU A 521","None","1.43A","3mjrA-2gj4A:0.0","3mjrA-2gj4A:16.41"],["3THR_A_C2FA1100_0","GLYCINE N-METHYLTRANSFERASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"SER A 812;LEU A 683;THR A 487;ARG A 489","None","1.40A","3thrB-2gj4A:undetectable","3thrB-2gj4A:15.79"],["3VW7_A_VPXA2001_1","PROTEINASE-ACTIVATED RECEPTOR 1, LYSOZYME","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"LEU A 384;LEU A 463;ALA A 451;ALA A 373;TYR A 374","None","1.10A","3vw7A-2gj4A:undetectable","3vw7A-2gj4A:19.91"],["4BQF_A_QPSA951_1","ALPHA-GLUCAN PHOSPHORYLASE 2, CYTOSOLIC","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"TRP A 361;ARG A 398;GLU A 405;ARG A 409","None","0.59A","4bqfA-2gj4A:46.9","4bqfA-2gj4A:45.35"],["4BQF_B_QPSB951_1","ALPHA-GLUCAN PHOSPHORYLASE 2, CYTOSOLIC","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"TRP A 361;ARG A 398;GLU A 405;ARG A 409","None","0.55A","4bqfB-2gj4A:46.8","4bqfB-2gj4A:45.35"],["4D33_A_MTLA870_0","NITRIC OXIDE SYNTHASE, ENDOTHELIAL","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"ASN A 440;GLU A 385;ASN A 376;ASP A 339","None","1.10A","4d33A-2gj4A:undetectable","4d33A-2gj4A:20.24"],["4D33_B_MTLB870_0","NITRIC OXIDE SYNTHASE, ENDOTHELIAL","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"ASN A 440;GLU A 385;ASN A 376;ASP A 339","None","1.10A","4d33B-2gj4A:undetectable","4d33B-2gj4A:20.24"],["4D39_A_MTLA870_0","NITRIC OXIDE SYNTHASE, ENDOTHELIAL","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"ASN A 440;GLU A 385;ASN A 376;ASP A 339","None","1.04A","4d39A-2gj4A:undetectable","4d39A-2gj4A:20.24"],["4D39_B_MTLB870_0","NITRIC OXIDE SYNTHASE, ENDOTHELIAL","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"ASN A 440;GLU A 385;ASN A 376;ASP A 339","None","1.08A","4d39B-2gj4A:undetectable","4d39B-2gj4A:20.24"],["4EYZ_A_CCSA109_0","CELLULOSOME-RELATED PROTEIN MODULE FROM RUMINOCOCCUS FLAVEFACIENS THAT RESEMBLES PAPAIN-LIKE CYSTEINE PEPTIDASES","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ASN A 481;PHE A 479;VAL A 452;HIS A 459;ALA A 673","None","1.35A","4eyzA-2gj4A:undetectable","4eyzA-2gj4A:14.43"],["4EYZ_B_CCSB109_0","CELLULOSOME-RELATED PROTEIN MODULE FROM RUMINOCOCCUS FLAVEFACIENS THAT RESEMBLES PAPAIN-LIKE CYSTEINE PEPTIDASES","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ASN A 481;PHE A 479;VAL A 452;HIS A 459;ALA A 673","None","1.33A","4eyzB-2gj4A:undetectable","4eyzB-2gj4A:14.43"],["4KT0_A_PQNA2001_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1;PHOTOSYSTEM I REACTION CENTER SUBUNIT IX","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"GLY A 135;ARG A 138;ALA A 141;GLY A 132;LEU A 198","PLR A 940 ( 3.8A);None;None;None;None","1.06A","4kt0A-2gj4A:undetectable;4kt0J-2gj4A:undetectable","4kt0A-2gj4A:22.56;4kt0J-2gj4A:4.56"],["5C0O_H_SAMH301_0","TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE TRMI","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ALA A 140;GLY A 132;GLY A 137;GLY A 135;LEU A 131","None;None;None;PLR A 940 ( 3.8A);None","0.80A","5c0oH-2gj4A:undetectable","5c0oH-2gj4A:15.80"],["5HYR_A_ESTA601_1","ESTROGEN RECEPTOR","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"LEU A 222;ALA A 246;GLU A 273;ARG A 269;HIS A 201","None;None;None;None;SO4 A 942 ( 3.9A)","1.49A","5hyrA-2gj4A:undetectable","5hyrA-2gj4A:15.69"],["5KC4_E_RBFE201_2","RIBOFLAVIN TRANSPORTER RIBU","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"LYS A 608;ASP A 283;ILE A 623","None","0.81A","5kc4E-2gj4A:undetectable","5kc4E-2gj4A:12.74"],["5N5D_A_SAMA306_1","METHYLTRANSFERASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"LEU A 652;ILE A 125;GLU A 124;ASP A 128","None","0.96A","5n5dA-2gj4A:3.1","5n5dA-2gj4A:13.93"],["5TUD_D_ERMD1201_2","5-HYDROXYTRYPTAMINE RECEPTOR 2B,SOLUBLE CYTOCHROME B562 CHIMERA","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"LEU A 198;VAL A 200;LEU A 349;GLU A 357","None","0.85A","5tudD-2gj4A:undetectable","5tudD-2gj4A:19.33"],["5UIG_A_EDTA501_0","ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"ASN A 696;THR A 691;ILE A 458;GLU A 698","None","1.35A","5uigA-2gj4A:undetectable","5uigA-2gj4A:17.41"],["5VNC_C_GCSC801_1","GLYCOGEN [STARCH] SYNTHASE ISOFORM 2","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",7,"GLY A 135;HIS A 377;VAL A 455;ASN A 484;LYS A 574;GLU A 672;GLY A 675","PLR A 940 ( 3.8A);None;None;None;PLR A 940 (-2.8A);PLR A 940 ( 4.5A);PLR A 940 (-3.3A)","0.70A","5vncC-2gj4A:18.0","5vncC-2gj4A:6.48"],["6D8F_A_ACTA803_0","UNCHARACTERIZED PROTEIN","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"GLU A 778;LEU A 738;ARG A 739","None","0.78A","6d8fA-2gj4A:2.1","6d8fA-2gj4A:22.02"],["6EXI_A_ADNA502_0","ADENOSYLHOMOCYSTEINASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"THR A 671;THR A 668;ASN A 284;LEU A 380;HIS A 571","None","1.17A","6exiA-2gj4A:4.9","6exiA-2gj4A:7.77"],["6EXI_B_ADNB502_0","ADENOSYLHOMOCYSTEINASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"THR A 671;THR A 668;ASN A 284;LEU A 380;HIS A 571","None","1.16A","6exiB-2gj4A:2.3","6exiB-2gj4A:7.77"],["6EXI_C_ADNC502_0","ADENOSYLHOMOCYSTEINASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"THR A 671;THR A 668;ASN A 284;LEU A 380;HIS A 571","None","1.15A","6exiC-2gj4A:4.9","6exiC-2gj4A:7.77"],["6EXI_D_ADND502_0","ADENOSYLHOMOCYSTEINASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"THR A 671;THR A 668;ASN A 284;LEU A 380;HIS A 571","None","1.16A","6exiD-2gj4A:3.7","6exiD-2gj4A:7.77"],["6GNE_A_ACRA602_1","-","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"GLY A 134;GLY A 135;ASP A 339;VAL A 455;ASN A 484;GLY A 675","PLR A 940 (-3.6A);PLR A 940 ( 3.8A);None;None;None;PLR A 940 (-3.3A)","0.69A","6gneA-2gj4A:22.8","6gneA-2gj4A:20.89"],["6GNE_B_ACRB602_1","-","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",7,"GLU A  88;GLY A 134;GLY A 135;ASP A 339;VAL A 455;ASN A 484;GLY A 675","None;PLR A 940 (-3.6A);PLR A 940 ( 3.8A);None;None;None;PLR A 940 (-3.3A)","0.78A","6gneB-2gj4A:22.8","6gneB-2gj4A:20.89"],["6GNF_A_QPSA602_1","-","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ASP A 339;HIS A 341;ASN A 484;GLU A 672;GLY A 675","None;None;None;PLR A 940 ( 4.5A);PLR A 940 (-3.3A)","0.77A","6gnfA-2gj4A:21.6","6gnfA-2gj4A:21.75"],["6GNF_C_QPSC602_2","-","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"ASP A 339;HIS A 341;ASN A 484;GLU A 672;GLY A 675","None;None;None;PLR A 940 ( 4.5A);PLR A 940 (-3.3A)","0.76A","6gnfC-2gj4A:21.9","6gnfC-2gj4A:21.75"],["6GNG_A_QPSA601_1","-","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"GLY A 134;LEU A 136;ASP A 339;HIS A 341;ASN A 484","PLR A 940 (-3.6A);None;None;None;None","0.88A","6gngA-2gj4A:21.8","6gngA-2gj4A:21.83"],["6GNG_A_QPSA601_2","-","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"GLU A  88;GLY A 135;HIS A 377;VAL A 455;GLU A 672;GLY A 675","None;PLR A 940 ( 3.8A);None;None;PLR A 940 ( 4.5A);PLR A 940 (-3.3A)","0.72A","6gngA-2gj4A:21.8","6gngA-2gj4A:21.83"],["6GNG_B_QPSB601_2","-","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"GLU A  88;GLY A 134;GLY A 135;GLY A 612;ASN A 284","None;PLR A 940 (-3.6A);PLR A 940 ( 3.8A);None;None","1.03A","6gngB-2gj4A:21.8","6gngB-2gj4A:21.83"],["6GNG_B_QPSB601_2","-","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",6,"GLU A  88;GLY A 134;GLY A 135;LEU A 136;HIS A 341;ASN A 284","None;PLR A 940 (-3.6A);PLR A 940 ( 3.8A);None;None;None","1.12A","6gngB-2gj4A:21.8","6gngB-2gj4A:21.83"],["6GNG_B_QPSB601_2","-","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"GLU A  88;GLY A 134;LEU A 136;HIS A 341;ASN A 284","None;PLR A 940 (-3.6A);None;None;None","1.07A","6gngB-2gj4A:21.8","6gngB-2gj4A:21.83"],["6HQB_A_PQNA2001_0","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1;PHOTOSYSTEM I REACTION CENTER SUBUNIT IX","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",5,"GLY A 135;ARG A 138;ALA A 141;GLY A 132;LEU A 198","PLR A 940 ( 3.8A);None;None;None;None","1.05A","6hqbA-2gj4A:undetectable;6hqbJ-2gj4A:undetectable","6hqbA-2gj4A:6.92;6hqbJ-2gj4A:4.56"],["6HZP_A_FVTA501_0","PEPTIDE ABC TRANSPORTER PERMEASE","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"VAL A 629;GLN A 740;ASN A 588;ILE A 584","None","1.01A","6hzpA-2gj4A:undetectable","6hzpA-2gj4A:21.17"],["6JI6_A_ACTA305_0","GLUTATHIONE S-TRANSFERASE CLASS-MU 26 KDA ISOZYME","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"GLY A 137;LEU A 136;SER A  86;TYR A  84","None","0.95A","6ji6A-2gj4A:undetectable","6ji6A-2gj4A:14.34"],["6MA7_A_TPFA602_0","CYTOCHROME P450 3A4","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"ARG A 398;ALA A 364;THR A 368;ILE A 346","None","0.97A","6ma7A-2gj4A:undetectable","6ma7A-2gj4A:7.02"],["6MN4_C_AM2C301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",4,"ASP A 339;HIS A 443;HIS A 341;GLU A 382","None","1.15A","6mn4C-2gj4A:undetectable","6mn4C-2gj4A:16.07"],["6NJ9_K_SAMK500_1","HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC","2gj4","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","Oryctolagus cuniculus",3,"THR A 378;GLU A  88;ASN A 284","None","0.56A","6nj9K-2gj4A:4.0","6nj9K-2gj4A:20.07"]]